|Bid||18.41 x 800|
|Ask||18.48 x 1200|
|Day's Range||18.10 - 22.80|
|52 Week Range||12.88 - 59.49|
|Beta (5Y Monthly)||2.90|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Constellation Pharmaceuticals (CNST) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Every investor in Constellation Pharmaceuticals, Inc. (NASDAQ:CNST) should be aware of the most powerful shareholder...
Constellation Pharmaceuticals, Inc. (CNST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).